8,779 Shares in VanEck Pharmaceutical ETF $PPH Acquired by Leuthold Group LLC

Leuthold Group LLC purchased a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 8,779 shares of the company’s stock, valued at approximately $906,000. Leuthold Group LLC owned 0.08% of VanEck Pharmaceutical ETF at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. AlphaCore Capital LLC acquired a new position in VanEck Pharmaceutical ETF in the 4th quarter worth approximately $31,000. IFP Advisors Inc grew its stake in shares of VanEck Pharmaceutical ETF by 53.7% during the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after purchasing an additional 153 shares during the period. Advisory Services Network LLC acquired a new stake in shares of VanEck Pharmaceutical ETF during the 3rd quarter worth approximately $41,000. CWM LLC grew its stake in shares of VanEck Pharmaceutical ETF by 36.3% during the 4th quarter. CWM LLC now owns 511 shares of the company’s stock worth $53,000 after purchasing an additional 136 shares during the period. Finally, Farther Finance Advisors LLC grew its stake in shares of VanEck Pharmaceutical ETF by 64.7% during the 4th quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock worth $74,000 after purchasing an additional 282 shares during the period.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ PPH opened at $100.84 on Monday. The stock has a market capitalization of $956.97 million, a price-to-earnings ratio of 20.21 and a beta of 0.46. VanEck Pharmaceutical ETF has a 12 month low of $81.74 and a 12 month high of $112.58. The firm’s 50 day simple moving average is $102.77 and its 200-day simple moving average is $103.23.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 7th. Stockholders of record on Wednesday, April 1st were paid a dividend of $0.8441 per share. This represents a $3.38 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Wednesday, April 1st. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.